Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review

Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study

(2021) Aliza Hussain et al.   European Journal of Preventive Cardiology

Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease

(2021) Minghao Kou et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Effects of liraglutide on the metabolism of triglyceride‐rich lipoproteins in type 2 diabetes

(2021) Marja‐Riitta Taskinen et al.   DIABETES OBESITY & METABOLISM

Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study

(2021) Arnaud D. Kaze et al.   Journal of the American Heart Association

Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients

(2020) Javad Alizargar et al.   Cardiovascular Diabetology

Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy

(2020) Hayato Tada et al.   CIRCULATION JOURNAL

Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naïve young adults: A nationwide cohort study

(2020) Heesun Lee et al.   European Journal of Preventive Cardiology

The return of triglycerides and revival of omega-3 fatty acids!

(2020) Jean Ferrières   Archives of Cardiovascular Diseases

High triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population: a cross-sectional study

(2020) Ki-Woong Nam et al.   Cardiovascular Diabetology

Triglyceride to HDL-cholesterol ratio and the incidence risk of type 2 diabetes in community dwelling adults: A longitudinal 12-year analysis of the Korean Genome and Epidemiology Study

(2020) Tae-Kyeong Lim et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study

(2020) Morten Kaltoft et al.   EUROPEAN HEART JOURNAL

Novel emerging therapies in atherosclerosis targeting lipid metabolism

(2020) Manasvi Gupta et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

From Classical Laboratory Parameters to Novel Biomarkers for the Diagnosis of Venous Thrombosis

(2020) Larisa Anghel et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The association between triglycerides and incident cardiovascular disease: What is “optimal”?

(2020) Tsion Aberra et al.   Journal of Clinical Lipidology

Contribution of remnant cholesterol to cardiovascular risk

(2020) Anne Langsted et al.   JOURNAL OF INTERNAL MEDICINE

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

(2020) Edward K. Duran et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a)

(2020) Xiang Zhang et al.   Lipids in Health and Disease

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

(2020) Kausik K. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia

(2020) Frederick J. Raal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Triglyceride to high-density lipoprotein cholesterol ratio and risk of atherosclerotic cardiovascular disease in a Chinese population

(2020) Long Zhou et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Lipid lowering therapy in cardiovascular disease: From myth to molecular reality

(2020) Philipp Mourikis et al.   PHARMACOLOGY & THERAPEUTICS

Is it possible to predict the complexity of peripheral artery disease with atherogenic index?

(2020) Engin Mesut et al.   Vascular

Triglycerides and residual risk

(2020) Antonio J. Vallejo-Vaz et al.   Current Opinion in Endocrinology Diabetes and Obesity

Causes and Consequences of Hypertriglyceridemia

(2020) Chris J. Packard et al.   Frontiers in Endocrinology

ApoB48-remnant lipoproteins are associated with increased cardiometabolic risk in adolescents

(2020) Jacqueline A. Krysa et al.   ATHEROSCLEROSIS

Predictors of endothelial function improvement in patients with mild hypertriglyceridemia without evidence of coronary artery disease treated with purified eicosapentaenoic acid

(2020) Kazuo Fukumoto et al.   ATHEROSCLEROSIS

Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions

(2020) Aliza Hussain et al.   Current Atherosclerosis Reports

Remnant lipoproteins

(2020) Carlos A. Aguilar Salinas et al.   CURRENT OPINION IN LIPIDOLOGY

Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy

(2020) Oluwayemisi Esan et al.   Drug Design Development and Therapy

Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides

(2020) A. Mantovani et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Triglyceride Glucose Index and Prognosis of Patients With Ischemic Stroke

(2020) Yimo Zhou et al.   Frontiers in Neurology

Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke

(2020) Shuai Yuan et al.   ANNALS OF NEUROLOGY

Hypertriglyceridemia

(2020) Anna Wolska et al.   CURRENT OPINION IN LIPIDOLOGY

The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease

(2020) Britt E. Heidemann et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Atherogenic index of plasma predicts cerebrovascular accident occurrence in antineutrophil cytoplasmic antibody-associated vasculitis

(2020) Sung Soo Ahn et al.   Lipids in Health and Disease

Poor Control of Plasma Triglycerides Is Associated with Early Decline of Estimated Glomerular Filtration Rates in New-Onset Type 2 Diabetes in China: Results from a 3-Year Follow-Up Study

(2020) Chuan Wang et al.   Journal of Diabetes Research

Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years

(2020) Hidehiro Kaneko et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes

(2020) Marja-Riitta Taskinen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study

(2020) Sangmo Hong et al.   BMC Medicine

The Atherogenic Index of Plasma is Independently Associated with Symptomatic Carotid Artery Stenosis

(2020) Ravi Garg et al.   Journal of Stroke & Cerebrovascular Diseases

Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk

(2020) John R. Burnett et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Real-world analyses of patients with elevated atherosclerotic cardiovascular disease risk from the Optum Research Database

(2020) Peter P Toth et al.   Future Cardiology

The Efficacy and Safety of Pemafibrate in Patients with Type 2 Diabetes and Elevated Triglyceride levels: 52-Week Data From The PROVIDE Study

(2019) Eiichi Araki et al.   DIABETES OBESITY & METABOLISM

Triglycerides and cardiovascular risk: Apolipoprotein B holds the key

(2019) Jane Stock   ATHEROSCLEROSIS

Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis

(2019) Giuliano Generoso et al.   Current Opinion in Endocrinology Diabetes and Obesity

High triglyceride/HDL cholesterol ratio is associated with silent brain infarcts in a healthy population

(2019) Ki-Woong Nam et al.   BMC Neurology

Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care

(2019) Alessandra da Silva et al.   Cardiovascular Diabetology

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   ATHEROSCLEROSIS

Association of Antihyperglycemic Therapy with Risk of Atrial Fibrillation and Stroke in Diabetic Patients

(2019) Cristina-Mihaela Lăcătușu et al.   Medicina-Lithuania

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

(2019) Joseph L. Witztum et al.   NEW ENGLAND JOURNAL OF MEDICINE

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

(2019) William E Boden et al.   EUROPEAN HEART JOURNAL

Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease

(2019) Ma Feng et al.   European Journal of Preventive Cardiology

Empagliflozin's Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease

(2019) Takahiro Sawada et al.   Journal of Atherosclerosis and Thrombosis

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

(2018) Hidenori Arai et al.   Journal of Atherosclerosis and Thrombosis

Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Review of Echocardiographic Findings in Patients with Obstructive Sleep Apnea

(2018) Radu Sascău et al.   Canadian Respiratory Journal

Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

(2018) JoAnn E. Manson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

(2018) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors

(2017) M. Yldau van der Ende et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Hypertriglyceridaemia and risk of coronary artery disease

(2017) Željko Reiner   Nature Reviews Cardiology

The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis

(2016) Jan Borén et al.   CURRENT OPINION IN LIPIDOLOGY

Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative

(2016) Giuseppina T. Russo et al.   DIABETES CARE

Peripheral Arterial Disease Incidence and Associated Risk Factors in a Mediterranean Population-based Cohort. The REGICOR Study

(2016) A. Velescu et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Asociación entre la razón triglicéridos/colesterol HDL y ateromatosis carotídea en mujeres posmenopáusicas de mediana edad

(2016) Walter Masson et al.   Endocrinologia y Nutricion

Epidemiology of Peripheral Artery Disease

(2015) M. H. Criqui et al.   CIRCULATION RESEARCH

Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials

(2008) A. Pandor et al.   JOURNAL OF INTERNAL MEDICINE

Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation

(2008) Limin Wang et al.   JOURNAL OF LIPID RESEARCH